Literature DB >> 29227252

[MORTALITY AND MORBIDITY FROM PROSTATE CANCER IN THE REPUBLIC OF KAZAKHSTAN FROM 2007 TO 2016].

Е Ospanov1, Т Adylkhanov1, Sh Tokanova1, Yu Semenova1, М Dauletyarova1, S Bolsynbekova1, N Zhumykbaeva1.   

Abstract

Worldwide, prostate cancer is the second most common male malignancy after lung cancer. However, prostate cancer is less common for the Asian population. We performed statistical analysis of official data on newly diagnosed cases of prostate cancer based on the annual reports of cancer hospitals in the Republic of Kazakhstan for the period of 10 years (2007-2016). We observed an increase in the incidence of prostate cancer among the population of Kazakhstan for the period of 2007-2016, which may be due to the screening program, which started in 2013. In the country as a whole, there has been a decrease in mortality over the past two years. The peak incidence of prostate cancer falls at the age of 70 years and older, while at the age of below 40 years this disease is seen only sporadically. Since 2009, there has been an increase in the detection of prostate cancer in the early (I-II) stages, which is associated with screening tests based on evaluation of serum PSA levels.

Entities:  

Mesh:

Year:  2017        PMID: 29227252

Source DB:  PubMed          Journal:  Georgian Med News        ISSN: 1512-0112


  3 in total

1.  Epidemiology of Prostate Cancer in the Republic of Kazakhstan.

Authors:  Dariga Smailova; Erlan Ospanov; Meruert Gazaliyeva; Dilyara Kaidarova; Oxana Shatkovskaya; Zhanar Zamanbekova; Kuralay Amrenova; Tatyana Belikhina; Tasbolat Adylkhanov; Ardak Omarbekov; Marzhan Dauletyarova; Lyudmila Pivina; Yuliya Semenova
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

2.  Epidemiological Characteristics of Male Reproductive Cancers in the Republic of Kazakhstan: Ten-Year Trends.

Authors:  Khussan Talipbayevich Umurzakov; Gulnar Metallovna Shalgumbayeva; Dilyara Radikovna Kaydarova; Yerbol Smail; Askar Ibrayev; Sayan Oralchanovich Sagidullin; Yuliya Mikhailovna Semenova
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

3.  Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program.

Authors:  Dariga S Smailova; Elisa Fabbro; Serik E Ibrayev; Luca Brusati; Yuliya M Semenova; Umutzhan S Samarova; Farida S Rakhimzhanova; Sabit M Zhussupov; Zaituna A Khismetova; Hengameh Hosseini
Journal:  Prostate Cancer       Date:  2020-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.